Literature DB >> 23151320

Scaffold hopping strategy toward original pyrazolines as selective CB₂ receptor ligands.

Vincent Gembus1, Christophe Furman, Régis Millet, Roxane Mansouri, Philippe Chavatte, Vincent Levacher, Jean-François Brière.   

Abstract

In line of a scaffold hopping strategy of pyrazole structures, especially known as potent CB(2) receptor antagonists, we exploited an original and convergent synthesis of a new class of C4-benzyl pyrazolines and derivatives from readily available hydrazones and enones (two or three steps). Making use of a mixture of resin supported reagents strategy an efficient domino process allowed the easy construction of various dihydropyrazoles in 63-83% yields. The obtained family of pyrazolines featured significant hCB(2)/hCB(1) selectivity in favor of hCB(2) receptors while more than 1000-3000 nM affinity was only measured for hCB(1) receptors. This is closely related to pyrazole SR144528 inverse agonist/antagonist, although a partial agonist behavior in the [(35)S]-GTPγS binding assay was mainly measured in our case pointing out a functional switch in action. Furthermore, this hCB(2) selectivity is unique within the pyrazoline CB ligands although the affinity ranging from 251 to 689 nM remains to be improved which give, however, an opportunity for further structure-activity relationship.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23151320     DOI: 10.1016/j.ejmech.2012.10.031

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Systematic Modification of Zingerone Reveals Structural Requirements for Attraction of Jarvis's Fruit Fly.

Authors:  Benjamin L Hanssen; Soo Jean Park; Jane E Royer; Joanne F Jamie; Phillip W Taylor; Ian M Jamie
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

2.  Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2'-Oxidase.

Authors:  Sangmi Oh; Yumi Park; Curtis A Engelhart; Joshua B Wallach; Dirk Schnappinger; Kriti Arora; Michelle Manikkam; Brian Gac; Hongwu Wang; Nicholas Murgolo; David B Olsen; Michael Goodwin; Michelle Sutphin; Danielle M Weiner; Laura E Via; Helena I M Boshoff; Clifton E Barry
Journal:  J Med Chem       Date:  2018-11-05       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.